Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* clinically and histologically proven painful bullous/erosive or atrophic forms of OLP~Exclusion Criteria:~* lichenoid lesions smoking systemic conditions pregnancy or breast feeding known hypersnstivity or severe adverse effects to the treatment drugs or to any ingredient of their preparation

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- tacrolimus/corticosteroid (Type: EXPERIMENTAL): topical steroids ( triamcinolone acetonide 0.1 %), tacrolimus paste and tacrolimus patch
- corticosteroids (Type: ACTIVE_COMPARATOR): topical corticosteroid
- tacrolimus (Type: ACTIVE_COMPARATOR): topical tacrolimus patch and tacrolimus paste

Based on this trial design, predict the completion outcome and termination type (if applicable).